166 related articles for article (PubMed ID: 15480793)
1. Diet and the frequency of the alanine:glyoxylate aminotransferase Pro11Leu polymorphism in different human populations.
Caldwell EF; Mayor LR; Thomas MG; Danpure CJ
Hum Genet; 2004 Nov; 115(6):504-9. PubMed ID: 15480793
[TBL] [Abstract][Full Text] [Related]
2. Variability in kidney stone incidence between black and white South Africans: AGT Pro11Leu polymorphism is not a factor.
Theka T; Rodgers AL; Webber D; O'Ryan C
J Endourol; 2014 May; 28(5):577-81. PubMed ID: 24344980
[TBL] [Abstract][Full Text] [Related]
3. Frequency of the AGT Pro11Leu polymorphism in humans: Does diet matter?
Ségurel L; Lafosse S; Heyer E; Vitalis R
Ann Hum Genet; 2010 Jan; 74(1):57-64. PubMed ID: 20059472
[TBL] [Abstract][Full Text] [Related]
4. Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase.
Danpure CJ
Biochimie; 1993; 75(3-4):309-15. PubMed ID: 8507692
[TBL] [Abstract][Full Text] [Related]
5. Molecular aetiology of primary hyperoxaluria type 1.
Danpure CJ
Nephron Exp Nephrol; 2004; 98(2):e39-44. PubMed ID: 15499210
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1.
Zhang X; Roe SM; Hou Y; Bartlam M; Rao Z; Pearl LH; Danpure CJ
J Mol Biol; 2003 Aug; 331(3):643-52. PubMed ID: 12899834
[TBL] [Abstract][Full Text] [Related]
7. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
Fargue S; Knight J; Holmes RP; Rumsby G; Danpure CJ
Biochim Biophys Acta; 2016 Jun; 1862(6):1055-62. PubMed ID: 26854734
[TBL] [Abstract][Full Text] [Related]
8. Diet and Adaptive Evolution of Alanine-Glyoxylate Aminotransferase Mitochondrial Targeting in Birds.
Wang BJ; Xia JM; Wang Q; Yu JL; Song Z; Zhao H
Mol Biol Evol; 2020 Mar; 37(3):786-798. PubMed ID: 31702777
[TBL] [Abstract][Full Text] [Related]
9. Variable peroxisomal and mitochondrial targeting of alanine: glyoxylate aminotransferase in mammalian evolution and disease.
Danpure CJ
Bioessays; 1997 Apr; 19(4):317-26. PubMed ID: 9136629
[TBL] [Abstract][Full Text] [Related]
10. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.
Danpure CJ
Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096
[TBL] [Abstract][Full Text] [Related]
11. Multiple adaptive losses of alanine-glyoxylate aminotransferase mitochondrial targeting in fruit-eating bats.
Liu Y; Xu H; Yuan X; Rossiter SJ; Zhang S
Mol Biol Evol; 2012 Jun; 29(6):1507-11. PubMed ID: 22319153
[TBL] [Abstract][Full Text] [Related]
12. Alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting in human hereditary kidney stone disease.
Danpure CJ; Lumb MJ; Birdsey GM; Zhang X
Biochim Biophys Acta; 2003 Apr; 1647(1-2):70-5. PubMed ID: 12686111
[TBL] [Abstract][Full Text] [Related]
13. Molecular adaptation of alanine:glyoxylate aminotransferase targeting in primates.
Holbrook JD; Birdsey GM; Yang Z; Bruford MW; Danpure CJ
Mol Biol Evol; 2000 Mar; 17(3):387-400. PubMed ID: 10723739
[TBL] [Abstract][Full Text] [Related]
14. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.
Lumb MJ; Danpure CJ
J Biol Chem; 2000 Nov; 275(46):36415-22. PubMed ID: 10960483
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1.
Danpure CJ
J Nephrol; 1998; 11 Suppl 1():8-12. PubMed ID: 9604801
[TBL] [Abstract][Full Text] [Related]
16. A unique molecular basis for enzyme mistargeting in primary hyperoxaluria type 1.
Leiper JM; Danpure CJ
Clin Chim Acta; 1997 Oct; 266(1):39-50. PubMed ID: 9435987
[TBL] [Abstract][Full Text] [Related]
17. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1.
Kukreja A; Lasaro M; Cobaugh C; Forbes C; Tang JP; Gao X; Martin-Higueras C; Pey AL; Salido E; Sobolov S; Subramanian RR
Nucleic Acid Ther; 2019 Apr; 29(2):104-113. PubMed ID: 30676254
[TBL] [Abstract][Full Text] [Related]
18. The ILE56 mutation on different genetic backgrounds of alanine:glyoxylate aminotransferase: Clinical features and biochemical characterization.
Dindo M; Mandrile G; Conter C; Montone R; Giachino D; Pelle A; Costantini C; Cellini B
Mol Genet Metab; 2020; 131(1-2):171-180. PubMed ID: 32792227
[TBL] [Abstract][Full Text] [Related]
19. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.
Danpure CJ; Purdue PE; Fryer P; Griffiths S; Allsop J; Lumb MJ; Guttridge KM; Jennings PR; Scheinman JI; Mauer SM
Am J Hum Genet; 1993 Aug; 53(2):417-32. PubMed ID: 8101040
[TBL] [Abstract][Full Text] [Related]
20. Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis.
Coulter-Mackie MB; Rumsby G
Mol Genet Metab; 2004; 83(1-2):38-46. PubMed ID: 15464418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
